About RGCS
RGCS is a company based in Thiruvananthapuram (India) founded in 2018. It operates as a B2B. RGCS operates in a competitive market with competitors including Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others.
- Headquarter Thiruvananthapuram, India
- SectorsHealthcare
- Website rgcs.in
- Legal Name Adoor Lifeline Medical Solutions Private Limited
- Date of Incorporation 16 Aug, 2017
- Jurisdiction Adoor, Kerala, India
- Annual Revenue₹3,570
FY 2024 · -100% YoY
- Net Loss-₹1.24 Cr
FY 2024 · -347840% margin
- EBITDA-₹1.24 Cr
FY 2024 · -347840% margin
Associated legal entities of RGCS
RGCS is associated with 2 registered companies on The Company Check; the primary company is Adoor Lifeline Medical Solutions Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Adoor Lifeline Medical Solutions Private Limited CIN U85320KL2017PTC050103 | Active | 16 Aug 2017 | Adoor, Kerala | ₹0.0 Cr | – | 3 | View details |
| Rgcs Homes Private Limited CIN U45400UP2019PTC116060 | Active | 22 Apr 2019 | Kanpur, Uttar Pradesh | ₹0.0 Cr | – | 2 | View details |
Board of directors of Adoor Lifeline Medical Solutions Private Limited (RGCS)
Adoor Lifeline Medical Solutions Private Limited is the primary company behind RGCS. The boards of the 2 registered companies of RGCS currently have 5 directors; the longest-serving is Cyriac Pappachan, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Cyriac Pappachan DIN 07904064 | Whole-time director | 16 Aug 2017 | 9 yrs 1 mo | Adoor Lifeline Medical Solutions Private Limited |
| Mathew Pappachen DIN 07904336 | Managing Director | 16 Aug 2017 | 9 yrs 1 mo | Adoor Lifeline Medical Solutions Private Limited |
| Pappachan Skariah Kalayil DIN 05300585 | Whole-time director | 16 Aug 2017 | 9 yrs 1 mo | Adoor Lifeline Medical Solutions Private Limited |
| Sanchit Agarwal DIN 08278659 | Director | 22 Apr 2019 | 7 yrs 5 mo | Rgcs Homes Private Limited |
| Rahul Gupta DIN 08278600 | Director | 22 Apr 2019 | 7 yrs 5 mo | Rgcs Homes Private Limited |
Financials of RGCS
Figures of Adoor Lifeline Medical Solutions Private Limited, the primary company behind RGCS, for FY 2024. Revenue was ₹3,570 (-100% year on year). Net loss was -₹1.24 Cr (-347840% margin). EBITDA was -₹1.24 Cr (-347840% margin). Revenue has grown at a compounded annual rate of -93% over three years and -77% over five years.
- ₹3,570Revenue · FY 2024 · -100% YoY
- -₹1.24 CrNet loss · -347840% margin
- -₹1.24 CrEBITDA · -347840% margin
- ₹10 LakhPaid-up capital
- -93%Revenue CAGR, 3 years
- -77%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Adoor Lifeline Medical Solutions Private Limited are on its company page.
Detailed financial statements for RGCS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of RGCS
RGCS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, ArcherDX, Variantyx, ImaginAb and Lantern Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| variantyx.com | 2014 | Boston, United States | $110.5M | 122 | Genomics data analysis platform for healthcare diagnostics is offered. | |
| imaginab.com | 2007 | Los Angeles, United States | $59.64M | 17 | ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | |
| lanternpharma.com | 2013 | Dallas, United States | $7.12M | 23 | Drug and companion diagnostics for multi-drug resistant cancers are developed. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| strataoncology.com | 2015 | Ann Arbor, United States | $139.15M | 125 | Genetic sequencing is provided for late-stage cancer patients. | |
| rgentatx.com | 2018 | Cambridge, United States | $90M | 11 | RNA-based therapeutics are developed for multiple disorders. | |
| lifecell.in | 2004 | Chennai, India | $61.21M | 1,188 | LifeCell is engaged in cord blood banking services. | |
| creativebio.cn | 2015 | Guangzhou, China | $219.65M | – | Cancer detection kits and screening services are provided. |
Detailed competitors of RGCS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to RGCS
10 companies that operate in the same segment as RGCS (Clinical Genomics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Panomic profiling technologies are developed for cancer precision medicine. | 1996 | Irving, Texas, United States | USD 1.23 B | – | 1,339 | |
Genomics-based diagnostic tests for cancer are provided. | 2010 | Cambridge, Massachusetts, United States | USD 96.5 M | – | – | |
Digital molecular biology analytics are developed for disease management. | 2012 | Carlsbad, California, United States | USD 95.02 M | – | 46 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Genomic database for clinical research is provided. | 2015 | San Francisco, California, United States | USD 435 M | – | – | |
Genomic sequencing and diagnosis software is provided for healthcare. | 2011 | Menlo Park, California, United States | USD 87.3 M | USD 69.65 M | 229 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RGCS
RGCS was founded in 2018.
RGCS is headquartered in Thiruvananthapuram, India. It is registered at Thiruvananthapuram, Kerala, India.
The primary company behind RGCS, Adoor Lifeline Medical Solutions Private Limited, reported revenue of ₹3,570 for FY 2024, down 100% year on year.
RGCS, founded in 2018 in Thiruvananthapuram, India, focuses on providing healthcare solutions, advancing biotech innovations, genetic testing, and ngs sequencing. Provides comprehensive NGS sequencing solutions for diagnosing genetic disorders. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
RGCS's top competitors include Natera, ImaginAb and Lantern Pharma.
RGCS is associated with 2 legal entities: Adoor Lifeline Medical Solutions Private Limited, Rgcs Homes Private Limited.
The legal entities of RGCS currently have 5 directors, including Sanchit Agarwal, Rahul Gupta, Cyriac Pappachan and others.